Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus

Latest in Family Medicine

Reuters Health • The Doctor's Channel Daily Newscast

Benefit of caffeine therapy for neonatal apnea fades by school age

NEW YORK (Reuters Health) – While respiratory stimulation with caffeine in very preterm infants with apnea of prematurity reduces rates of impairment at 18 months, the benefits are no longer apparent at 5 years, trial investigators report in the Journal...

Reuters Health • The Doctor's Channel Daily Newscast

Coronary artery lesions develop if Kawasaki disease treatment is delayed

NEW YORK (Reuters Health) – Intravenous immunoglobulin therapy started 10 days or more after onset of Kawasaki disease (KD) suppresses inflammation but does not prevent coronary artery lesions, a Japanese team reports in Pediatrics online January...

Reuters Health • The Doctor's Channel Daily Newscast

Fenofibrate safe in type 2 diabetes and moderate renal impairment

NEW YORK (Reuters Health) – Fenofibrate is safe to use in patients with type 2 diabetes and moderate renal impairment, researchers conclude in a report online December 30 in Diabetes Care. Fenofibrate’s propensity to elevate plasma creatinine is...